Valhi (VHI) Competitors $15.87 -0.02 (-0.13%) Closing price 04/15/2025 03:58 PM EasternExtended Trading$15.86 -0.01 (-0.06%) As of 04/15/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VHI vs. CC, PRM, BAK, UAN, PCT, NGVT, TROX, WLKP, ECVT, and OECShould you be buying Valhi stock or one of its competitors? The main competitors of Valhi include Chemours (CC), Perimeter Solutions (PRM), Braskem (BAK), CVR Partners (UAN), PureCycle Technologies (PCT), Ingevity (NGVT), Tronox (TROX), Westlake Chemical Partners (WLKP), Ecovyst (ECVT), and Orion (OEC). These companies are all part of the "chemicals" industry. Valhi vs. Chemours Perimeter Solutions Braskem CVR Partners PureCycle Technologies Ingevity Tronox Westlake Chemical Partners Ecovyst Orion Chemours (NYSE:CC) and Valhi (NYSE:VHI) are both small-cap basic materials companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, community ranking, profitability, earnings, valuation, risk, media sentiment, dividends and analyst recommendations. Does the media favor CC or VHI? In the previous week, Chemours had 20 more articles in the media than Valhi. MarketBeat recorded 21 mentions for Chemours and 1 mentions for Valhi. Chemours' average media sentiment score of 0.66 beat Valhi's score of 0.00 indicating that Chemours is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 9 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 4 Negative mention(s) 1 Very Negative mention(s) Positive Valhi 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate CC or VHI? Chemours currently has a consensus price target of $21.56, suggesting a potential upside of 93.76%. Valhi has a consensus price target of $20.00, suggesting a potential upside of 26.02%. Given Chemours' stronger consensus rating and higher possible upside, analysts clearly believe Chemours is more favorable than Valhi.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chemours 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56Valhi 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Is CC or VHI a better dividend stock? Chemours pays an annual dividend of $1.00 per share and has a dividend yield of 9.0%. Valhi pays an annual dividend of $0.32 per share and has a dividend yield of 2.0%. Chemours pays out 175.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Valhi pays out 8.5% of its earnings in the form of a dividend. Which has stronger earnings & valuation, CC or VHI? Valhi has lower revenue, but higher earnings than Chemours. Valhi is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChemours$5.78B0.29-$238M$0.5719.52Valhi$2.10B0.21-$12.10M$3.784.20 Does the MarketBeat Community believe in CC or VHI? Chemours received 403 more outperform votes than Valhi when rated by MarketBeat users. However, 63.41% of users gave Valhi an outperform vote while only 60.67% of users gave Chemours an outperform vote. CompanyUnderperformOutperformChemoursOutperform Votes63760.67% Underperform Votes41339.33% ValhiOutperform Votes23463.41% Underperform Votes13536.59% Which has more risk and volatility, CC or VHI? Chemours has a beta of 1.84, suggesting that its stock price is 84% more volatile than the S&P 500. Comparatively, Valhi has a beta of 1.08, suggesting that its stock price is 8% more volatile than the S&P 500. Do institutionals and insiders believe in CC or VHI? 76.3% of Chemours shares are held by institutional investors. Comparatively, 3.8% of Valhi shares are held by institutional investors. 0.5% of Chemours shares are held by company insiders. Comparatively, 0.1% of Valhi shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is CC or VHI more profitable? Valhi has a net margin of 4.29% compared to Chemours' net margin of 1.51%. Chemours' return on equity of 26.54% beat Valhi's return on equity.Company Net Margins Return on Equity Return on Assets Chemours1.51% 26.54% 2.41% Valhi 4.29%6.90%3.36% SummaryChemours beats Valhi on 14 of the 20 factors compared between the two stocks. Remove Ads Get Valhi News Delivered to You Automatically Sign up to receive the latest news and ratings for VHI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VHI vs. The Competition Export to ExcelMetricValhiIndustrial inorganic chemicals IndustryMaterials SectorNYSE ExchangeMarket Cap$449.04M$25.33B$2.96B$18.52BDividend Yield2.09%3.73%5.23%4.23%P/E Ratio5.0911.0577.2031.15Price / Sales0.212.6824,272,056,611,966,700.0025.69Price / Cash12.6456.3524.3217.53Price / Book0.368.575.194.29Net Income-$12.10M$731.97M$154.96M$1.02B7 Day Performance-3.26%-1.24%5.26%-0.79%1 Month Performance-12.54%-12.68%2.39%-6.88%1 Year Performance5.03%-24.93%15.94%1.74% Valhi Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VHIValhi2.8109 of 5 stars$15.87-0.1%$20.00+26.0%+5.5%$449.04M$2.10B5.092,250News CoveragePositive NewsGap DownCCChemours3.8871 of 5 stars$11.55+2.4%$22.00+90.5%-57.3%$1.73B$5.78B20.266,600Analyst ForecastShort Interest ↑News CoveragePRMPerimeter Solutions3.9252 of 5 stars$9.99+0.2%$16.00+60.2%+39.6%$1.50B$560.97M-71.35240Positive NewsGap DownBAKBraskem2.3108 of 5 stars$3.49+2.6%$9.75+179.4%-63.0%$1.39B$77.41B-0.988,310News CoverageUANCVR Partners2.7921 of 5 stars$72.35+0.5%N/A-6.6%$1.24B$525.32M12.56300Insider TradeNews CoveragePositive NewsPCTPureCycle Technologies2.5571 of 5 stars$6.46+3.7%$12.50+93.5%+20.0%$1.16BN/A-4.31120News CoveragePositive NewsNGVTIngevity2.5791 of 5 stars$31.74-0.7%$53.83+69.6%-29.1%$1.16B$1.41B-2.682,050Analyst DowngradeNews CoverageTROXTronox4.3967 of 5 stars$5.46+4.4%$12.93+136.8%-67.9%$862.34M$3.07B-17.616,610Analyst ForecastWLKPWestlake Chemical Partners4.1308 of 5 stars$22.36-0.5%N/A+4.3%$787.94M$1.14B12.78150News CoveragePositive NewsECVTEcovyst4.2256 of 5 stars$5.91+0.5%$10.00+69.2%-41.1%$693.64M$704.49M12.85880OECOrion4.457 of 5 stars$11.74+0.4%$22.00+87.4%-51.7%$665.12M$1.88B15.651,600News CoveragePositive NewsGap Down Remove Ads Related Companies and Tools Related Companies Chemours Alternatives Perimeter Solutions Alternatives Braskem Alternatives CVR Partners Alternatives PureCycle Technologies Alternatives Ingevity Alternatives Tronox Alternatives Westlake Chemical Partners Alternatives Ecovyst Alternatives Orion Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:VHI) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Valhi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Valhi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.